Skip to main content

Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · IEX Real-Time Price · USD
1.24
-0.04 (-3.13%)
Dec 29, 2023, 4:00 PM EST - Market closed

Akebia Therapeutics Market Cap

Akebia Therapeutics has a market cap or net worth of $233.60 million as of December 29, 2023. Its market cap has increased by 209.00% in one year.

Market Cap
233.60M
Enterprise Value
239.91M
1-Year Change
209.00%
Ranking
#3567
Category
Micro-Cap
Stock Price
$1.24

Market Cap Chart

Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $233.60M, a decrease of -52.14%. That is a compound annual growth rate of -7.26%.

History

DateMarket Cap% Change
Dec 29, 2023233.60M
-3.11%
Dec 28, 2023241.10M
6.63%
Dec 27, 2023226.10M
0.85%
Dec 26, 2023224.20M-
Dec 22, 2023224.20M
-0.84%
Dec 21, 2023226.10M-
Dec 20, 2023226.10M
0.85%
Dec 19, 2023224.20M
3.51%
Dec 18, 2023216.60M-
Dec 15, 2023216.60M
1.74%
Dec 14, 2023212.90M
1.82%
Dec 13, 2023209.10M
3.72%
Dec 12, 2023201.60M
-3.59%
Dec 11, 2023209.10M
-1.78%
Dec 8, 2023212.90M
-3.40%
Dec 7, 2023220.40M
0.87%
Dec 6, 2023218.50M
3.55%
Dec 5, 2023211.00M
-2.59%
Dec 4, 2023216.60M
7.44%
Dec 1, 2023201.60M
0.95%
Nov 30, 2023199.70M
6.00%
Nov 29, 2023188.40M
4.15%
Nov 28, 2023180.90M
-3.00%
Nov 27, 2023186.50M
-1.01%
Nov 24, 2023188.40M
1.02%
View and export this data all the way back to 2014. Start Free Trial.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Allakos 238.81M
Talis Biomedical 236.04M
Stoke Therapeutics 234.88M
Prelude Therapeutics 234.13M
Atai Life Sciences 234.07M
Harvard Bioscience 228.38M
Ovid Therapeutics 227.59M
Alimera Sciences 226.44M
Market Cap Rankings